(USD) | Mar 2024 | Q/Q |
---|---|---|
Revenue | 2.4B | +3% |
Gross Profit | 771MM | - |
Cost Of Revenue | 1.6B | +3% |
Operating Income | 300MM | +12% |
Operating Expenses | 471MM | - |
Net Income | 194MM | +1% |
G&A | 440MM | +8% |
Amortization | 29MM | +7% |
Interest Expense | 49MM | +7% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Transaction is part of wide-ranging collaboration to combine Quest's oncology expertise and scale with PathAI's AI and digital pathology innovations to speed diagnosis, improve quality and reduce costs SECAUCUS, NJ and BOSTON, MA / ACCESSWIRE / May ...
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, announced today that Murali Balakumar, a veteran information technology healthcare business leader, has been named Senior Vice President and Chief Information and Digital Officer (CIDO).
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
Quest Diagnostics' (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.
NORTHAMPTON, MA / ACCESSWIRE / May 2, 2024 / Quest Diagnostics: At a glance: Quest worked with St. James Health in Newark to provide no-cost Blueprint for Wellness® screenings during a Choose Healthy Life event to celebrate expansion of Newark, NJ-based ...
PathAI is selling its diagnostics assets, including a Tennessee laboratory, but will continue to support its biopharmaceutical customers.
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and PathAI, a global provider of artificial intelligence-powered technology for pathology, today announced a multi-faceted collaboration designed to accelerate the adoption of digital and AI pathology innovations to improve quality, speed and efficiency in diagnosing cancer and other diseases.
Foundation grant will help NYC-based nonprofit expand reach of its innovative curriculum to 50 schools in Baltimore and Houston; funding will also support film screening tour of award-winning documentary to highlight importance of health equity through ...
A week ago, Quest Diagnostics Incorporated ( NYSE:DGX ) came out with a strong set of first-quarter numbers that could...
Comprehensive SWOT Analysis: Quest Diagnostics Inc's Financial and Strategic Position